[1]
S. Ansell, S. Geyer, P. Kurtin, K. Rowland, P. Flynn, and R. Morton, “Anti-tumor activity of CCI-779 in relapsed mantle cell lymphoma”, Hematol Meeting Rep, vol. 1, no. 8, Jun. 2009.